Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial

Nutrition

Volumn 24, Issue 1, 2008, Pages 23-30

  Dodin, Sylvie ^a,b   Cunnane, Stephen C ^c   Mâsse, Benoît ^d   Lemay, André ^a   Jacques, Hélène ^b   Asselin, Geneviève ^a   Tremblay Mercier, Jennifer ^c   Marc, Isabelle ^a   Lamarche, Benoît ^b   Légaré, France ^a   Forest, Jean Claude ^a  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITY INSTITUTE OF GERIATRICS OF SHERBROOKE   (Canada)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Apolipoprotein; Cardiovascular disease; Flaxseed; Low density lipoprotein particle size; Menopause; 3 Fatty acid

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DOCOSAPENTAENOIC ACID; FATTY ACID; FIBRINOGEN; GLUCOSE; INSULIN; LIGNAN DERIVATIVE; LINOLEIC ACID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; OMEGA 3 FATTY ACID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY FIBER; DIETARY INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; LINSEED; LIPOPROTEIN METABOLISM; MENOPAUSE; NORMAL HUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; WHEAT GERM;

TRITICUM AESTIVUM;

EID: 36849058160     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2007.09.003     Document Type: Article

References (49)

1. Gorodeski G.I. Update on cardiovascular disease in post-menopausal women. Best Pract Res Clin Obstet Gynaecol 16 (2002) 329-355
2. Kalin M.F., and Zumoff B. Sex hormones and coronary disease: a review of the clinical studies. Steroids 55 (1990) 330-352
3. Kannel W.B., Hjortland M.C., McNamara P.M., and Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 85 (1976) 447-452
4. Lichtenstein A.H., Appel L.J., Brands M., Carnethon M., Daniels S., Franch H.A., et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114 (2006) 82-96
5. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
6. Dodin S., Lemay A., Jacques H., Légaré F., Forest J., and Mâsse B. The effects of flaxseed dietary supplement on lipid profile, bone mineral density and symptoms in menopausal women: a randomized double-blind wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 90 (2005) 1390-1397
7. Lemay A., Dodin S., Kadri N., Jacques H., and Forest J.C. Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstet Gynecol 100 (2002) 495-504
8. Lucas E.A., Wild R.D., Hammond L.J., Khalil D.A., Juma S., Daggy B.P., et al. Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 87 (2002) 1527-1532
9. Jenkins D.J., Kendall C.W., Vidgen E., Agarwal S., Rao A.V., Rosenberg R.S., et al. Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial. Am J Clin Nutr 69 (1999) 395-402
10. Adlercreutz H., Fotsis T., Lampe J., Wahala K., Makela T., Brunow G., et al. Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography-mass spectrometry. Scand J Clin Lab Invest 215 suppl (1993) 5-18
11. Sanghvi A., Divven W., and Seltman H. Inhibition of rat liver cholesterol 7-alpha hydroxylase and acetyl CoA:cholesterol acetyl transferase activities by enterodiol and enterolactone. In: Kritchevsky D. (Ed). Proceedings of the symposium on drugs affecting lipid metabolism (1984), Plenum Press, New York 311-322
12. Kitts D.D., Yuan Y.V., Wijewickreme A.N., and Thompson L.U. Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol Cell Biochem 202 (1999) 91-100
13. Hall A.V., Parbtani A., Clark W.F., Spanner E., Keeney M., Chin-Yee I., et al. Abrogation of MRL/lpr lupus nephritis by dietary flaxseed. Am J Kidney Dis 22 (1993) 326-332
14. Cunnane S.C., Ganguli S., Menard C., Liede A.C., Hamadeh M.J., Chen Z.Y., et al. High alpha-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans. Br J Nutr 69 (1993) 443-453
15. de Lorgeril M., Renaud S., Mamelle N., Salen P., Martin J.L., Monjaud I., et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343 (1994) 1454-1459
16. Dolecek T.A. Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial. Proc Soc Exp Biol Med 200 (1992) 177-182
17. Cunnane S.C., Hamadeh M.J., Liede A.C., Thompson L.U., Wolever T.M., and Jenkins D.J. Nutritional attributes of traditional flaxseed in healthy young adults. Am J Clin Nutr 61 (1995) 62-68
18. Council on Scientific Affairs. Dietary fiber and health. JAMA 262 (1989) 542-546
19. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226 (1957) 497-509
20. St-Pierre A.C., Ruel I.L., Cantin B., Dagenais G.R., Bernard P.M., Despres J.P., et al. Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation 104 (2001) 2295-2299
21. Tarpila S., Aro A., Salminen I., Tarpila A., Kleemola P., Akkila J., et al. The effect of flaxseed supplementation in processed foods on serum fatty acids and enterolactone. Eur J Clin Nutr 56 (2002) 157-165
22. Goyens P.L., and Mensink R.P. The dietary alpha-linolenic acid to linoleic acid ratio does not affect the serum lipoprotein profile in humans. J Nutr 135 (2005) 2799-2804
23. Harper C.R., Edwards M.J., DeFilipis A.P., and Jacobson T.A. Flaxseed oil increases the plasma concentrations of cardioprotective (n-3) fatty acids in humans. J Nutr 136 (2006) 83-87
24. Francois C.A., Connor S.L., Bolewicz L.C., and Connor W.E. Supplementing lactating women with flaxseed oil does not increase docosahexaenoic acid in their milk. Am J Clin Nutr 77 (2003) 226-233
25. Plourde M., and Cunnane S.C. Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 32 (2007) 619-634
26. Matthan N.R., Jalbert S.M., Lamon-Fava S., Dolnikowski G.G., Welty F.K., Barrett H.R., et al. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status. Arterioscler Thromb Vasc Biol 25 (2005) 1691-1696
27. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
28. Walldius G., Jungner I., Holme I., Aastveit A.H., Kolar W., and Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358 (2001) 2026-2033
29. Desroches S., Mauger J.F., Ausman L.M., Lichtenstein A.H., and Lamarche B. Soy protein favorably affects LDL size independently of isoflavones in hypercholesterolemic men and women. J Nutr 134 (2004) 574-579
30. Kratz M., Gulbahce E., von Eckardstein A., Cullen P., Cignarella A., Assmann G., et al. Dietary mono- and polyunsaturated fatty acids similarly affect LDL size in healthy men and women. J Nutr 132 (2002) 715-718
31. Liuzzo G., Biasucci L.M., Gallimore J.R., Grillo R.L., Rebuzzi A.G., Pepys M.B., et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331 (1994) 417-424
32. Nikander E., Kilkkinen A., Metsa-Heikkila M., Adlercreutz H., Pietinen P., Tiitinen A., et al. A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet Gynecol 101 (2003) 1213-1220
33. Teede H.J., Dalais F.S., and McGrath B.P. Dietary soy containing phytoestrogens does not have detectable estrogenic effects on hepatic protein synthesis in postmenopausal women. Am J Clin Nutr 79 (2004) 396-401
34. Jenkins D.J., Kendall C.W., Connelly P.W., Jackson C.J., Parker T., Faulkner D., et al. Effects of high- and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women. Metabolism 51 (2002) 919-924
35. D'Anna R., Baviera G., Corrado F., Cancellieri F., Crisafulli A., and Squadrito F. The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women. Acta Obstet Gynecol Scand 84 (2005) 474-477
36. Hall W.L., Vafeiadou K., Hallund J., Bugel S., Koebnick C., Reimann M., et al. Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 82 (2005) 1260-1268
37. Cara L., Armand M., Borel P., Senft M., Portugal H., Pauli A.M., et al. Long-term wheat germ intake beneficially affects plasma lipids and lipoproteins in hypercholesterolemic human subjects. J Nutr 122 (1992) 317-326
38. Cara L., Borel P., Armand M., Senft M., Lafont H., Portugal H., et al. Plasma lipid lowering effects of wheat germ in hypercholesterolemic subjects. Plant Foods Hum Nutr 41 (1991) 135-150
39. Vanharanta M., Voutilainen S., Rissanen T.H., Adlercreutz H., and Salonen J.T. Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study. Arch Intern Med 163 (2003) 1099-1104
40. Vanharanta M., Voutilainen S., Lakka T.A., van der Lee M., Adlercreutz H., and Salonen J.T. Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study. Lancet 354 (1999) 2112-2115
41. Lissin L.W., and Cooke J.P. Phytoestrogens and cardiovascular health. J Am Coll Cardiol 35 (2000) 1403-1410
42. Hu F.B., Stampfer M.J., Manson J.E., Rimm E.B., Wolk A., Colditz G.A., et al. Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr 69 (1999) 890-897
43. Albert C.M., Oh K., Whang W., Manson J.E., Chae C.U., Stampfer M.J., et al. Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation 112 (2005) 3232-3238
44. Pereira M.A., O'Reilly E., Augustsson K., Fraser G.E., Goldbourt U., Heitmann B.L., et al. Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med 164 (2004) 370-376
45. Brown L., Rosner B., Willett W.W., and Sacks F.M. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 69 (1999) 30-42
46. Fernandez M.L. Soluble fiber and nondigestible carbohydrate effects on plasma lipids and cardiovascular risk. Current opinion in lipidology 12 (2001) 35-40
47. Anderson J.W. Dietary fibre, complex carbohydrate and coronary artery disease. Can J Cardiol 11 (1995) (55G-62)
48. Anderson J.W., and Hanna T.J. Impact of nondigestible carbohydrates on serum lipoproteins and risk for cardiovascular disease. J Nutr 129 (1999) 1457S-66
49. Schneeman B.O. Gastrointestinal physiology and functions. Br J Nutr 88 suppl 2 (2002) S159-S163